iMacular Regeneration LLC

Atlanta, GA · Medtech · Private

Macular O-rings (MORs): implantable nitinol scaffold devices for supporting and positioning donor tissue in submacular space during AMD treatment

Grants
$382K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Tissue Support Structure (Macular O-Rings) for Reconstructing, Translocating or Transplanting Three-Dimensional Submacular Tissue Organoids in Age Related Macular Degeneration (AMD)$382,493
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1821CELLOPTIC, INC.——
1822CARRTECH LLC——
1823RIO PHARMACEUTICALS, INC.——
1824iMacular Regeneration LLC——
1825Caris Life Sciences——
1826FLOWPOINT MEDICAL INC——
1827LF PRINTECH LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3
  • Tissue Graft Fixturegranted
  • Tissue Carrierapplication
  • Tissue Graft Fixtureapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.